Mgr. Jaroslav Juráček, Ph.D.
Secretary EOSC-CZ, Community and user Support
correspondence Address:
Šumavská 525/33, 602 00 Brno
phone: | +420 549 49 3410 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 51
2020
-
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System
Cancers, year: 2020, volume: 12, edition: 8, DOI
2019
-
Analysis of circulating hypoxia-related microRNAs in transarterial chemoembolization with degradable and non-degradable embolic agents
Year: 2019, type: Appeared in Conference without Proceedings
-
Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma
Cancers, year: 2019, volume: 11, edition: 10, DOI
-
Identification of microRNA signatures in umbilical cord blood associated with maternal characteristics
PeerJ, year: 2019, volume: 7, edition: MAY, DOI
-
miR-376b and miR-4668 predict therapeutic response to sunitinib in metastatic renal cell carcinoma
Year: 2019, type: Conference abstract
-
MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients
CANCER GENOMICS & PROTEOMICS, year: 2019, volume: 16, edition: 5, DOI
-
miR-376b-3p jako biomarker odpovědi na léčbu sunitinibem u pacientů s metastatickým karcinomem ledviny.
Year: 2019, type: Conference abstract
-
Sekvenování krátkých RNA a validace vybraných MikroRNA v mozkomíšním moku u pacientů s mozkovými nádory
Year: 2019, type: Conference abstract
-
Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 3, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI